Anxiety
Articles about Anxiety
Beta-Blockers for Anxiety Are Everywhere Online. Are They Safe? Doctors Weigh in
Imagine you're about to give a presentation to a room full of people.
Awardees of spring 2024 Tier 1 pilot research grants report final project outcomes
The Population Health Initiative awarded 13 $25,000 Tier 1 pilot grants in spring quarter 2024 to interdisciplinary University of Washington research teams to investigate pressing population health challenges. The funded projects collectively sought to address grand challenges in areas including climate change, mental health, child health and substance use disorder. The purpose of these Tier...
VTGN DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors ...
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) --
When mood swings signal something more serious
The shift can be subtle at first. Your motivated teen who once enjoyed staying late at practice now wants to quit her favorite sport. Grades start slipping. You might notice changes in friendships or that the bedroom door stays closed...
Tonix Pharmaceuticals Presented Data On TONMYATM In Treating Patients With Fibromyalgia At The 2026 AAPM Painconnect Annual Meeting
(MENAFN - GlobeNewsWire - Nasdaq) TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 Treatment with TONMYA ...
VTGN DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Vistagen Therapeutics, Inc. ...
NEW YORK, March 07, 2026 (GLOBE NEWSWIRE) --
AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business ...
Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‐of‐Phase 2 meeting with the U.S. Food and Drug AdministrationOn-track for VLS-01 Phase 2 Elumina trial topline data readout anticipated in H2...
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ...
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (NASDAQ: VTGN) investors of an upcoming deadline involving a securities fraud class action lawsuit...
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYATM and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in adults in more than 15 years
VTGN DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. ...
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) --
Psychologists are finding more ways to use virtual reality in therapy
From Rett and Pitt-Hopkins to ALS: 5 Rare Diseases UC San Diego Researchers are Tackling in the Lab
This Rare Disease Day (February 28, 2026), read on to learn more about five orphan conditions, the people they affect and the UC San Diego Sanford Stem Cell Institute researchers fanning the flames of hope for patients around the globe.